Phase Genomics

Phase Genomics Inc is a biotechnology platform intended to make transformative discoveries in fields such as agriculture, human health, and industrial biology. The company's platform helps to exploit DNA structure for improved genome and metagenome assembly and facilitates the cultivation-independent assembly of bacterial genomes present in complex microbial communities, enabling researchers to make breakthrough discoveries by providing complete, accurate, detailed genomes and metagenomes available from any technology.In June 2022, Phase Genomics Inc announced $5.5MM in combined non-dilutive funding from the Bill and Melinda Gates Foundation and the National Institute of Allergy and Infectious Diseases (NIAID).In February 2021, Phase Genomics Inc. announced the receipt of a $1.7MM grant from the National Institute of Allergy and Infectious Diseases